Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk

Cancer Science

Volumn 97, Issue 8, 2006, Pages 724-728

  Kohno, Takashi ^a,b   Kunitoh, Hideo ^c   Toyama, Kaoru ^a,b   Yamamoto, Seiichiro ^c   Kuchiba, Aya ^d   Saito, Daizo ^e   Yanagitani, Noriko ^f   Ishihara, Shin Ichi ^f   Saito, Ryusei ^f   Yokota, Jun ^a,b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLTRANSFERASE 1; CYSTEINE; DNA GLYCOSYLTRANSFERASE; GENOMIC DNA; SERINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; JAPAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE HOMOLOGY; SMOKING; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; AGED; ALLELES; AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LUNG NEOPLASMS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 33745623943     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00240.x     Document Type: Article

References (26)

1. Parkin M, Je T, Boffetta P, Samet J, Shields PG, Caporaso NE. Lung cancer epidemiology and etiology. In: Harris CC, ed. World Health Organization Classification of Tumors: Pathology and Genetics, Tumours of Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004: 31-4.
2. Colvy T, Noguch IM, Henschk EC et al. Adenocarcinoma. In: Harris CC, ed. World Health Organization Classification of Tumors: Pathology and Genetics, Tumours of Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004: 35-44.
3. Boiteux S, Radicella JP. The human OGG1 gene: Structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 2000; 377: 1-8.
4. Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 2001; 3: 597-609.
5. Kohno T, Shinmura K, Tosaka M et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16: 3219-25.
6. Dherin C, Radicella JP, Dizdaroglu M, Boiteux S. Excision of oxidatively damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1 (Ser326Cys) protein which is frequently found in human populations. Nucl Acids Res 1999; 27: 4001-7.
7. Yamane A, Kohno T, Ito K et al. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cells in vivo. Carcinogenesis 2004; 25: 1689-94.
8. Lee AJ, Hodges NJ, Chipman JK. Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: Role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7,8-dihydro-2′-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomarkers Prev 2005; 14: 497-505.
9. Sugimura H, Kohno T, Wakai K et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1999; 8: 669-74.
10. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: A review of the functional and epidemiologic literature. Mol Carcinog 2005; 42: 127-41.
11. Wikman H, Risch A, Klimek F et al. hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population. Int J Cancer 2000; 88: 932-7.
12. Ito H, Hamajima N, Takezaki T et al. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol 2002; 12: 258-65.
13. Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 409-12.
14. Park J, Chen L, Tockman MS, Elahi A, Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 2004; 14: 103-9.
15. Hung RJ, Brennan P, Canzian F et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005; 97: 567-76.
16. Zienolddiny S, Campa D, Lind H et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2005.
17. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am J Epidemiol 2005; 162: 925-42.
18. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001; 18: 1059-68.
19. Sakiyama T, Kohno T, Mimaki S et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 2005; 114: 730-7.
20. Yoshimura K, Hanaoka T, Ohnami S et al. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: Data from population-based Japanese random samples. J Hum Genet 2003; 48: 654-8.
21. Breslow NE, Day NE. Statistical methods in cancer research, volume I - the analysis of case-control studies. IARC Sci Publ 1980: 5-338.
22. Sunaga N, Kohno T, Yanagitani N et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 2002; 11: 730-8.
23. Wynder EL, Hoffmann D. Smoking and lung cancer: Scientific challenges and opportunities. Cancer Res 1994; 54: 5284-95.
24. Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006; 118: 257-62.
25. Matsumoto S, Iwakawa R, Kohno T et al. Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma. Int J Cancer 2006; 118: 2498-504.
26. Toyooka S, Tokumo M, Shigematsu H et al. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 2006; 66: 1371-5.